Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000276:immunology; D019072:Antibiotic Prophylaxis / Q000009:adverse effects; D000906:Antibodies / Q000097:blood; D015313:Cefotetan / Q000009:adverse effects* / Q000276:immunology; D002511:Cephalosporins / Q000009:adverse effects* / Q000276:immunology; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology; D005260:Female; D006801:Humans; D008875:Middle Aged; D019990:Perioperative Care
D000900:Anti-Bacterial Agents; D000906:Antibodies; D002511:Cephalosporins; D015313:Cefotetan